In our case, the ADC increased slightly over a 3 year period.
2
Mean ADC value and minimum ADC value of the tumor were measured.
3
Paired-sample t-test and the Bland-Altman method were used for ADC data analysis.
4
A lot of ADCs do a lot of damage at long range.
5
ADC maps in conjunction with T2W images were used for target delineation.
1
Enfortumab vedotin is a new type of treatment called an antibody-drugconjugate.
2
Background: Glembatumumab vedotin is an antibody-drugconjugate that produced preliminary clinical activity against advanced melanoma in a phase 1 dose-escalation trial.
3
Also monoclonal antibody as a carrier of anticancer drug was mentioned and its problems was discussed from the aspect of pharmacokinetics of antibody-drugconjugate.
4
Antibody-drugconjugates (ADCs) have achieved great success in cancer therapy in recent years.
5
Antibody-DrugConjugates (ADC)s-based therapy has been proposed as potential strategy to treat this pediatric malignancy.
1
It develops antibodydrugconjugates (ADCs) for the treatment of both solid and hematological cancers.
2
Abbvie plans to combine antibodies being developed by both companies with its antibodydrugconjugates, described by researchers as "guided missiles".
3
Antibodydrugconjugates like enfortumab vedotin have shown promising activity in clinical trials.
4
Antibodydrugconjugates (ADCs) are a therapeutic class offering promise for cancer therapy.
5
Antibodydrugconjugates (ADCs) are becoming an important new class of therapeutic agents for the treatment of cancer.
Ús de adcs en anglès
1
A lot of ADCs do a lot of damage at long range.
2
ADCs also face competition from another treatment approach called bispecific antibodies.
3
In 2013, the Basel-based company had about a dozen experimental ADCs.
4
ADCs are generally delivered via repeated infusions, similar to chemotherapy.
5
In addition, we observed that ADC accumulation retro-inhibited ADCS activity.
6
ADCs are increasingly being used as targeted therapies for cancer.
7
ADCs use the targeting ability of monoclonal antibodies to deliver cell-killing drugs to specific cells.
8
Antibody-drug conjugates (ADCs) have achieved great success in cancer therapy in recent years.
9
Antibody drug conjugates (ADCs) are a therapeutic class offering promise for cancer therapy.
10
Some early ADCs fell apart in the bloodstream, leading to failure or unacceptable damage to healthy tissues.
11
It develops antibody drug conjugates (ADCs) for the treatment of both solid and hematological cancers.
12
The corresponding ADCs at the biopsy location were compared with the histopathologic outcomes of the biopsy specimens.
13
Looking Beyond Load Balancers We found the solution to meet our needs in the form of next-generation ADCs.
14
One of our most popular ADCs.
15
ADCs recognize tumor-specific cell surface antigens and are internalized into lysosomes where proteolytic enzymes release the cytotoxic payloads.
16
Many experimental ADCs, however, failed due to the complexity of pairing the right antibody with the appropriate toxic agent.